Current status of invasive fungal infections. New diagnostic techniques and antifungal agents;Situación actual de las infecciones fúngicas invasivas. Las nuevas técnicas diagnósticas y los nuevos antifúngicos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue SUPPL. 14, 2008, Pages 1-6

  Gurguí, Mercedes ^a   Cuenca Estrella, Manuel ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Beta D glucan assay; Galactomannan detection; Invasive aspergillosis; Invasive candidiasis

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; GALACTOMANNAN; MICAFUNGIN; BETA 1,3 GLUCAN; BETA GLUCAN; BETA-1,3-GLUCAN; ECHINOCANDIN; MANNAN;

CANDIDIASIS; DIAGNOSTIC PROCEDURE; HOSPITAL COST; HOSPITALIZATION; HUMAN; INVASIVE CANDIDIASIS; MORTALITY; MYCOSIS; OPPORTUNISTIC INFECTION; SHORT SURVEY; SYSTEMIC MYCOSIS; ASPERGILLOSIS; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE PREDISPOSITION; FUNGEMIA; HEMATOLOGIC DISEASE; IMMUNE DEFICIENCY; INTENSIVE CARE; META ANALYSIS; MICROBIOLOGY; NEOPLASM; REVIEW;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; BETA-GLUCANS; CANDIDIASIS; CLINICAL TRIALS AS TOPIC; DIABETES COMPLICATIONS; DISEASE SUSCEPTIBILITY; ECHINOCANDINS; FUNGEMIA; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; INTENSIVE CARE; MANNANS; META-ANALYSIS AS TOPIC; MYCOSES; NEOPLASMS; OPPORTUNISTIC INFECTIONS;

EID: 69249231154     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(08)76586-8     Document Type: Article

References (53)

1. A.N. Malani, and C.A. Kauffman Changing epidemiology of rare mould infections: implications for therapy Drugs 67 2007 1803 1812
2. J.J. Osorio, A.R. Roman, and J. Torre-Cisneros Spectrum and risk factors of invasive fungal infection Enferm Infecc Microbiol Clin 25 2007 467 476 (Pubitemid 47309633)
3. M.J. DiNubile, R.J. Lupinacci, K.M. Strohmaier, C.A. Sable, and N.A. Kartsonis Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial J Crit Care 22 2007 237 244
4. J. Filioti, K. Spiroglou, C.P. Panteliadis, and E. Roilides Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome Intensive Care Med 33 2007 1272 1283 (Pubitemid 47036901)
5. M. Mean, O. Marchetti, and T. Calandra Bench-to-bedside review: Candida infections in the intensive care unit Crit Care 12 2008 204
6. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 2004 309 317 (Pubitemid 39050477)
7. B. Almirante, D. Rodriguez, B.J. Park, M. Cuenca-Estrella, A.M. Planes, and M. Almela Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 J Clin Microbiol 43 2005 1829 1835 (Pubitemid 40491227)
8. M.A. Pfaller, and D.J. Diekema Epidemiology of invasive candidiasis: a persistent public health problem Clin Microbiol Rev 20 2007 133 163
9. P.M. Olaechea, M. Palomar, C. Leon-Gil, F. Alvarez-Lerma, R. Jorda, and J. Nolla-Salas Economic impact of Candida colonization and Candida infection in the critically ill patient Eur J Clin Microbiol Infect Dis 23 2004 323 330 (Pubitemid 38669943)
10. A.F. Shorr, D.R. Lazarus, J.H. Sherner, W.L. Jackson, M. Morrel, and V.J. Fraser Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia Crit Care Med 35 2007 1077 1083 (Pubitemid 46598958)
11. S. Gabardi, D.W. Kubiak, A.K. Chandraker, and S.G. Tullius Invasive fungal infections and antifungal therapies in solid organ transplant recipients Transpl Int 20 2007 993 1015 (Pubitemid 350043839)
12. G. Maschmeyer, A. Haas, and O.A. Cornely Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients Drugs 67 2007 1567 1601 (Pubitemid 47267298)
13. J.W. Baddley, P.G. Pappas, A.C. Smith, and S.A. Moser Epidemiology of Aspergillus terreus at a university hospital J Clin Microbiol 41 2003 5525 5529
14. J.J. Caston, M.J. Linares, C. Gallego, A. Rivero, P. Font, and F. Solis Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi Chest 131 2007 230 236 (Pubitemid 46122998)
15. A.A. Panackal, A. Imhof, E.W. Hanley, and K.A. Marr Aspergillus ustus infections among transplant recipients Emerg Infect Dis 12 2006 403 408 (Pubitemid 43306264)
16. A.C. Labbe, S.H. Su, M. Laverdiere, J. Pepin, C. Patino, and S. Cohen High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation Biol Blood Marrow Transplant 13 2007 1192 1200 (Pubitemid 47413018)
17. L. Pagano, M. Caira, A. Nosari, M.T. Van Lint, A. Candoni, and M. Offidani Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne Clin Infect Dis 45 2007 1161 1170 (Pubitemid 47580314)
18. R. Martino, M. Subira, M. Rovira, C. Solano, L. Vazquez, and G.F. Sanz Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients Br J Haematol 116 2002 475 482 (Pubitemid 34155525)
19. A. Upton, K.A. Kirby, P. Carpenter, M. Boeckh, and K.A. Marr Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality Clin Infect Dis 44 2007 531 540 (Pubitemid 46233255)
20. J. Gavalda, O. Len, R. San Juan, J.M. Aguado, J. Fortun, and C. Lumbreras Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study Clin Infect Dis 41 2005 52 59 (Pubitemid 40863744)
21. P. Grossi, C. Farina, R. Fiocchi, and G.D. Dalla Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients Transplantation 70 2000 112 116
22. W. Meersseman, K. Lagrou, J. Maertens, and E. Van Wijngaerden Invasive aspergillosis in the intensive care unit Clin Infect Dis 45 2007 205 216 (Pubitemid 47044802)
23. J. Garnacho-Montero, R. Amaya-Villar, C. Ortiz-Leyba, C. Leon, F. Alvarez-Lerma, J. Nolla-Salas, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome Crit Care 9 2005 R191 R199
24. W. Meersseman, S.J. Vandecasteele, A. Wilmer, E. Verbeken, W.E. Peetermans, and E. Van Wijngaerden Invasive aspergillosis in critically ill patients without malignancy Am J Respir Crit Care Med 170 2004 621 625 (Pubitemid 39202203)
25. N.G. Almyroudis, D.A. Sutton, P. Linden, M.G. Rinaldi, J. Fung, and S. Kusne Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature Am J Transplant 6 2006 2365 2374 (Pubitemid 44359422)
26. M.M. Roden, T.E. Zaoutis, W.L. Buchanan, T.A. Knudsen, T.A. Sarkisova, R.L. Schaufele, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases Clin Infect Dis 41 2005 634 653
27. M. Torres-Narbona, J. Guinea, J. Martinez-Alarcon, T. Pelaez, and E. Bouza In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest Antimicrob Agents Chemother 51 2007 1126 1129 (Pubitemid 46355313)
28. K.J. Cortez, E. Roilides, F. Quiroz-Telles, J. Meletiadis, C. Antachopoulos, T. Knudsen, et al. Infections caused by Scedosporium spp Clin Microbiol Rev 21 2008 157 197
29. M. Nucci, and E. Anaissie Fusarium infections in immunocompromised patients Clin Microbiol Rev 20 2007 695 704 (Pubitemid 47623773)
30. W.E. Dismukes, P.G. Pappas, and J.D. Sobel Clinical Mycology 2003 Oxford University Press New York
31. E.M. O'Shaughnessy, Y.M. Shea, and F.G. Witebsky Laboratory diagnosis of invasive mycoses Infect Dis Clin North Am 17 2003 135 158
32. M. Richardson, and M. Ellis Clinical and laboratory diagnosis Hosp Med 61 2000 610 614
33. I. Gadea, M. Cuenca-Estrella, E. Martin, J. Peman, J. Ponton, and J.L. Rodriguez-Tudela Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing Enferm Infecc Microbiol Clin 25 2007 336 340 (Pubitemid 47202773)
34. J. Ponton, M.D. Moragues, and G. Quindos Non-culture-based diagnostics R.A. Calderone Candida y candidiasis 2002 ASM Press Washington 395 425
35. C.D. Pfeiffer, J.P. Fine, and N. Safdar Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis Clin Infect Dis 42 2006 1417 1427
36. J. Maertens, K. Theunissen, E. Verbeken, K. Lagrou, J. Verhaegen, and M. Boogaerts Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients Br J Haematol 126 2004 852 860 (Pubitemid 39273827)
37. W. Meersseman, K. Lagrou, J. Maertens, A. Wilmer, G. Hermans, S. Vanderschueren, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients Am J Respir Crit Care Med 177 2008 27 34
38. K.A. Marr, M. Laverdiere, A. Gugel, and W. Leisenring Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay Clin Infect Dis 40 2005 1762 1769 (Pubitemid 40799945)
39. M.A. Mennink-Kersten, D. Ruegebrink, R.R. Klont, A. Warris, N.M. Blijlevens, and J.P. Donnelly Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure J Clin Microbiol 46 2008 1391 1397 (Pubitemid 351563585)
40. Z. Odabasi, G. Mattiuzzi, E. Estey, H. Kantarjian, F. Saeki, and R.J. Ridge Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome Clin Infect Dis 39 2004 199 205 (Pubitemid 38971490)
41. L. Ostrosky-Zeichner, B.D. Alexander, D.H. Kett, J. Vazquez, P.G. Pappas, and F. Saeki Multicenter clinical evaluation of the (1->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans Clin Infect Dis 41 2005 654 659 (Pubitemid 41170353)
42. J.W. Pickering, H.W. Sant, C.A.P. Bowles, W.L. Roberts, and G.L. Woods Evaluation of a (1->3)-{beta}-D-Glucan Assay for Diagnosis of Invasive Fungal Infections J Clin Microbiol 43 2005 5957 5962 (Pubitemid 43100644)
43. L. Senn, J.O. Robinson, S. Schmidt, M. Knaup, N. Asahi, S. Satomura, et al. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia Clin Infect Dis 46 2008 878 885
44. B. Sendid, D. Caillot, B. Baccouch-Humbert, L. Klingspor, M. Grandjean, and A. Bonnin Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults J Clin Microbiol 41 2003 4551 4558 (Pubitemid 37259756)
45. M.D. Moragues, N. Ortiz, J.R. Iruretagoyena, J.C. Garcia-Ruiz, E. Amutio, and A. Rojas Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis Enferm Infecc Microbiol Clin 22 2004 83 88 (Pubitemid 38585446)
46. J.P. Donnelly Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go Clin Infect Dis 42 2006 487 489
47. R. McMullan, L. Metwally, P.V. Coyle, S. Hedderwick, B. McCloskey, H.J. O'Neill, et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults Clin Infect Dis 46 2008 890 896
48. M. Cuenca-Estrella, A. Gomez-Lopez, E. Mellado, M.J. Buitrago, A. Monzon, and J.L. Rodriguez-Tudela Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi Antimicrob Agents Chemother 50 2006 917 921 (Pubitemid 43327795)
49. J. Gavalda, and I. Ruiz Guidelines for the treatment of infection due to Aspergillus spp Enferm Infecc Microbiol Clin 21 2003 571 578 (Pubitemid 38057086)
50. J. Gavalda, and I. Ruiz Guidelines for the treatment of invasive fungal infection. Invasive fungal infection by Candida spp. Invasive Fungal Infection Study Group (MICOMED) and Infection in Transplantation Study Group (GESITRA) of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC) Enferm Infecc Microbiol Clin 21 2003 498 508
51. P.G. Pappas, J.H. Rex, J.D. Sobel, S.G. Filler, W.E. Dismukes, T.J. Walsh, et al. Guidelines for treatment of candidiasis Clin Infect Dis 38 2004 161 189
52. T.J. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, and K.A. Marr Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 2008 327 360 (Pubitemid 351265310)
53. M. Cuenca-Estrella Combinations of antifungal agents in therapy-what value are they? J Antimicrob Chemother 54 2004 854 869 (Pubitemid 39529979)